Chestnut Hill, MA, United States of America

Keizo Koya

USPTO Granted Patents = 58 

 

Average Co-Inventor Count = 5.4

ph-index = 16

Forward Citations = 641(Granted Patents)

Forward Citations (Not Self Cited) = 396(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Brookline, MA (US) (1999 - 2014)
  • Chestnut Hill, MA (US) (2005 - 2017)

Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
58 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Keizo Koya in Biotechnology

Introduction: Keizo Koya, based in Chestnut Hill, MA, is an esteemed inventor known for his impressive portfolio of 58 patents. His work primarily focuses on advancing biotechnological applications, with a significant emphasis on novel strategies for protein expression and therapeutic interventions for proliferative disorders.

Latest Patents: Among Koya's most recent patents are significant advancements in the realm of protein expression. He has developed fusion proteins that comprise a protein expression-enhancing polypeptide linked to a target protein binding domain. These innovations are crucial for enhancing the expression and/or location of targeted proteins, aiding in restoring lost cellular functions, and providing treatment options for various diseases. Additionally, his patents disclose compounds aimed at treating proliferative disorders, including cancer. These compounds offer methods for utilizing their properties to benefit patients suffering from such conditions, paving the way for new therapeutic approaches.

Career Highlights: Throughout his career, Koya has made substantial contributions to the field of biotechnology through his innovative research and development efforts. His expertise has been an asset to renowned companies, including Synta Pharmaceuticals Corporation. His prolific patenting activity reflects his commitment to advancing scientific knowledge and creating practical solutions for complex medical challenges.

Collaborations: Koya has collaborated with notable researchers in the field, including Lijun Sun and Shoujun Chen. These partnerships have enhanced the quality and impact of his work, driving progress in the development of novel biotherapeutics.

Conclusion: Keizo Koya continues to be a driving force in biotechnological innovation. His extensive patent portfolio not only highlights his commitment to science but also positions him as a pivotal contributor to the advancement of therapeutic solutions for pressing health issues. As he progresses with his research, the impact of his work is likely to resonate through the scientific community and beyond, inspiring future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…